Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Board Review
CME
Careers
Cases
Conferences
Videos
Webinars
Podcasts
Advertising
Buyer's Guide
Vendors
25 for 25
2024
Featured News
SNMMI: Carson discusses Image of the Year
By
Will Morton
AuntMinnie.com
spoke with Richard Carson, PhD, from Yale University, at the SNMMI annual meeting about the 2024 Image of the Year.
June 11, 2024
SNMMI 2024 Image Gallery
June 10, 2024
Treatment paradigm shifting for men with prostate cancer
By
Will Morton
New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC).
June 28, 2024
SNMMI: PET/CT illuminates connection between CVD and cognitive impairment
By
Kate Madden Yee
PET/CT reveals a connection between cardiovascular disease (CVD) and cognitive impairment, according to research presented at SNMMI 2024.
June 12, 2024
SNMMI: PET-based protocol shows promise in radioligand therapy
By
Amerigo Allegretto
A PET-based scout dosimetry protocol can be feasible in treating lesions with yttrium-90 FAPI (Y-90 FAPI) radioligand therapy.
June 12, 2024
SNMMI: Lu-177 PSMA-617 shines for taxane-naive prostate cancer
By
Erik L. Ridley
The radiopharmaceutical Pluvicto improves survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy.
June 11, 2024
SNMMI: UW advances radioimmunotherapy At-211 production, trials
By
Liz Carey
Alpha-emitting astatine-211 (At-211) may open the door to new targeted radioimmunotherapy for treating blood cancer.
June 11, 2024
SNMMI: FAPI PET/CT shows promise in breast cancer staging
By
Amerigo Allegretto
A study presented at SNMMI suggests that FAPI PET/CT could be suitable for systemic staging of newly diagnosed breast cancer.
June 11, 2024
SNMMI: Study explores theranostic ‘cocktail’ for colon cancer
By
Will Morton
An animal study shows the feasibility of an approach in colon cancer that simultaneously uses alpha- and beta-emitting isotopes to target and kill cancer cells.
June 11, 2024
SNMMI: Ultralow dose PET protocol eliminates need for CT
By
Kate Madden Yee
A new ultralow dose imaging method used with long axial field-of-view PET scanners produces images with a radiopharmaceutical dose 50 times lower than the standard effective dose.
June 11, 2024
SNMMI: Nuclear medicine experiencing an ‘industrial revolution’
By
Erik L. Ridley
Recent growth in nuclear medicine has represented the equivalent of an “industrial revolution" for specialty, according to SNMMI President Helen Nadel, MD.
June 10, 2024
SNMMI: Nuclear medicine clinician-scientists need passion, stamina
By
Erik L. Ridley
Ora Israel, MD, shares what it takes to succeed as a nuclear medicine clinician-scientist in a video interview at SNMMI 2024.
June 10, 2024
GE HealthCare highlights new cyclotron at SNMMI 2024
By
AuntMinnie.com staff writers
GE HealthCare introduced the MINItrace Magni at the Society of Nuclear Medicine and Molecular Imaging annual meeting (SNMMI) annual meeting, a newly designed, small-footprint cyclotron for in-house production of commercial PET radiotracers.
June 10, 2024
SNMMI taps Urbain as president-elect
By
AuntMinnie.com staff writers
Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
June 10, 2024
Page 1 of 3
Next Page
